147 related articles for article (PubMed ID: 33774076)
1. Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria.
Hoppe BS; Advani R; Milgrom SA; Bakst RL; Ballas LK; Dabaja BS; Flowers CR; Ha CS; Mansur DB; Metzger ML; Pinnix CC; Plastaras JP; Roberts KB; Smith SM; Terezakis SA; Kirwan JM; Constine LS
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):36-44. PubMed ID: 33774076
[TBL] [Abstract][Full Text] [Related]
2. Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.
Lazarovici J; Terroir M; Arfi-Rouche J; Michot JM; Mussot S; Florea V; Ghigna MR; Dartigues P; Petrovanu C; Danu A; Fermé C; Ribrag V; Ghez D
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2018-2024. PubMed ID: 28634685
[TBL] [Abstract][Full Text] [Related]
3. Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study.
Ceriani L; Barrington S; Biggi A; Malkowski B; Metser U; Versari A; Martelli M; Davies A; Johnson PW; Zucca E; Chauvie S
Hematol Oncol; 2017 Dec; 35(4):548-553. PubMed ID: 27545416
[TBL] [Abstract][Full Text] [Related]
4. Updates in the Management of Primary Mediastinal B Cell Lymphoma.
Soueidy C; Kourie HR
Clin Lymphoma Myeloma Leuk; 2023 Dec; 23(12):866-873. PubMed ID: 37722943
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Vassilakopoulos TP; Papageorgiou SG; Angelopoulou MK; Chatziioannou S; Prassopoulos V; Karakatsanis S; Arapaki M; Mellios Z; Sachanas S; Kalpadakis C; Katodritou E; Leonidopoulou T; Kotsianidis I; Hatzimichael E; Kotsopoulou M; Dimou M; Variamis E; Boutsis D; Terpos E; Michali E; Karianakis G; Tsirkinidis P; Vadikolia C; Poziopoulos C; Pigaditou A; Vrakidou E; Siakantaris MP; Kyrtsonis MC; Symeonidis A; Anargyrou K; Papaioannou M; Chatziharissi E; Vervessou E; Tsirogianni M; Palassopoulou M; Gainaru G; Mainta C; Tsirigotis P; Assimakopoulou T; Konstantinidou P; Papadaki H; Dimopoulos MA; Pappa V; Karmiris T; Roussou P; Datseris I; Panayiotidis P; Konstantopoulos K; Pangalis GA; Rondogianni P
Ann Hematol; 2021 Sep; 100(9):2279-2292. PubMed ID: 33523289
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy in primary mediastinal B-cell lymphoma with positron emission tomography positivity after rituximab chemotherapy.
Filippi AR; Piva C; Giunta F; Bellò M; Chiappella A; Caracciolo D; Zotta M; Douroukas A; Ragona R; Vitolo U; Bisi G; Ricardi U
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):311-6. PubMed ID: 23916170
[TBL] [Abstract][Full Text] [Related]
7. The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review.
Cheah CY; Hofman MS; Seymour JF; Ritchie DS; Dickinson M; Wirth A; Prince HM; Wolf M; Januszcewicz EH; Carney DA; Herbert KE; Harrison SJ; Burbury KL; Tam CS
Leuk Lymphoma; 2015 Jan; 56(1):49-56. PubMed ID: 24724780
[TBL] [Abstract][Full Text] [Related]
8. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Pinnix CC; Dabaja B; Ahmed MA; Chuang HH; Costelloe C; Wogan CF; Reed V; Romaguera JE; Neelapu S; Oki Y; Rodriguez MA; Fayad L; Hagemeister FB; Nastoupil L; Turturro F; Fowler N; Fanale MA; Nieto Y; Khouri IF; Ahmed S; Medeiros LJ; Davis RE; Westin J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):113-21. PubMed ID: 25863759
[TBL] [Abstract][Full Text] [Related]
9. Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use?
Giunta F; Zotta M; Menga M; Balma M; Bellò M; Passera R; Filippi AR; Chiappella A; Ladetto M; Ricardi U; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):214-9. PubMed ID: 25669764
[TBL] [Abstract][Full Text] [Related]
10. Primary mediastinal large B cell lymphoma.
Yu Y; Dong X; Tu M; Wang H
Thorac Cancer; 2021 Nov; 12(21):2831-2837. PubMed ID: 34590432
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Pre-Radiation Therapy (18)F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus Radiation.
Filippi AR; Piva C; Levis M; Chiappella A; Caracciolo D; Bellò M; Bisi G; Vitolo U; Ricardi U
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1239-43. PubMed ID: 27130796
[TBL] [Abstract][Full Text] [Related]
12. Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach.
Hayden AR; Tonseth P; Lee DG; Villa D; Gerrie AS; Scott DW; Freeman CL; Slack GW; Farinha P; Skinnider B; Yenson PR; Benard F; Lo A; Pickles T; Wilson D; Connors JM; Sehn LH; Savage KJ
Blood; 2020 Dec; 136(24):2803-2811. PubMed ID: 32603413
[TBL] [Abstract][Full Text] [Related]
13. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma.
Alkhawtani RHM; Noordzij W; Glaudemans AWJM; van Rijn RS; van der Galiën HT; Balink H; Nijland M; Adams HJA; Huls G; van Meerten T; Kwee TC
Nucl Med Commun; 2018 Jun; 39(6):572-578. PubMed ID: 29672465
[TBL] [Abstract][Full Text] [Related]
15. Primary mediastinal B-cell lymphoma in the pediatric patient: Can a rational approach to therapy be based on adult studies?
Attias D; Hodgson D; Weitzman S
Pediatr Blood Cancer; 2009 May; 52(5):566-70. PubMed ID: 19058208
[TBL] [Abstract][Full Text] [Related]
16. How I treat primary mediastinal B-cell lymphoma.
Giulino-Roth L
Blood; 2018 Aug; 132(8):782-790. PubMed ID: 29976557
[TBL] [Abstract][Full Text] [Related]
17. Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography-Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study.
Parsons SK; Yu KS; Liu N; Kumar S; Fanale MA; Holmes K; Flores C; Surinach A; Flora DR; Evens AM
JCO Oncol Pract; 2023 Jun; 19(6):e867-e876. PubMed ID: 36947720
[TBL] [Abstract][Full Text] [Related]
18. Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.
Goldschmidt N; Kleinstern G; Orevi M; Paltiel O; Ben-Yehuda D; Gural A; Libster D; Lavie D; Gatt ME
Cancer Chemother Pharmacol; 2016 May; 77(5):1053-60. PubMed ID: 27056383
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.
Pinnix CC; Ng AK; Dabaja BS; Milgrom SA; Gunther JR; Fuller CD; Smith GL; Abou Yehia Z; Qiao W; Wogan CF; Akhtari M; Mawlawi O; Medeiros LJ; Chuang HH; Martin-Doyle W; Armand P; LaCasce AS; Oki Y; Fanale M; Westin J; Neelapu S; Nastoupil L
Blood Adv; 2018 Jun; 2(11):1334-1343. PubMed ID: 29895624
[TBL] [Abstract][Full Text] [Related]
20. Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions.
Lees C; Keane C; Gandhi MK; Gunawardana J
Br J Haematol; 2019 Apr; 185(1):25-41. PubMed ID: 30740662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]